Green Cross (005250)

Currency in KRW
9,840
+160(+1.65%)
Delayed Data·
005250 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
9,6809,950
52 wk Range
9,58018,010
Key Statistics
Bid/Ask
9,820.00 / 9,840.00
Prev. Close
9,680
Open
9,770
Day's Range
9,680-9,950
52 wk Range
9,580-18,010
Volume
36.3K
Average Volume (3m)
340.04K
1-Year Change
-40.2439%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
005250 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
RSI suggests the stock is in oversold territory

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Sell
Technical Indicators
Sell
Moving Averages
Sell
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate

Earnings

Latest Release
May 18, 2026
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS -1,978.21%
Dividend Yield
2.87%
Industry Median 1.00%
Annualized payout
300.00
Paid annually
5-Years Growth
-
Growth Streak

005250 Income Statement

Compare 005250 to Peers and Sector

Metrics to compare
005250
Peers
Sector
Relationship
P/E Ratio
−5.0x8.0x−0.5x
PEG Ratio
0.02−0.120.00
Price/Book
0.5x1.7x2.6x
Price / LTM Sales
0.2x4.8x3.0x
Upside (Analyst Target)
-59.4%58.6%
Fair Value Upside
Unlock27.7%10.2%Unlock

GC Corp. operates as a biotechnology company. The company provides prescription drugs and over-the-counter drugs; aseptic fill and finish services for drug manufacturing; and pharmaceutical logistics services. It also researches and develops plasma derivatives for von Willebrand disease and primary immunodeficiency; vaccines for mRNA flu, anthrax, tetanus, diphtheria, pertussis, tuberculosis, and varicella; recombinant treatments for acquired thrombotic thrombocytopenic purpura, fabry, hemophilia, hunterase, colon cancer, and hunter syndrome; and small molecules for gangliosidosis andalagille’s syndrome. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies, and clinical trials. Additionally, the company provides personalized nutrition injections. The company was formerly known as Green Cross Holdings Corporation and changed its name to GC Corp. in April 2026. The company was founded in 1967 and is headquartered in Yongin-Si, South Korea.

Employees
144

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
2.91M6.40%28.14B
Other Institutional Investors
12.73M28.04%123.25B
Public Companies & Retail Investors
29.76M65.55%288.10B
Total
45.4M100.00%439.49B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
MOGAM Biotechnology Research Institute9.04%4,102,19039,709,199
The National Pension Fund6.15%2,791,54927,022,194

People Also Watch

24,800
000240
+3.77%
14,620
035250
0.00%
15,700
000080
0.00%
16,760
138930
+3.27%
51,500
082740
-0.19%

FAQ

What Is the Green Cross (005250) Stock Price Today?

The Green Cross stock price today is 9,840 KRW.

What Stock Exchange Does Green Cross Trade On?

Green Cross is listed and trades on the Seoul Stock Exchange.

What Is the Stock Symbol for Green Cross?

The stock symbol for Green Cross is "005250."

Does Green Cross Pay Dividends? What’s The Current Dividend Yield?

The Green Cross dividend yield is 3.1%.

What Is the Green Cross Market Cap?

As of today, Green Cross market cap is 442.06B KRW.

What Is Green Cross's Earnings Per Share (TTM)?

The Green Cross EPS (TTM) is -1,978.

When Is the Next Green Cross Earnings Date?

Green Cross will release its next earnings report on Aug 18, 2026.

From a Technical Analysis Perspective, Is 005250 a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Green Cross Stock Split?

Green Cross has split 9 times.

How Many Employees Does Green Cross Have?

Green Cross has 144 employees.

What is the current trading status of Green Cross (005250)?

As of Jun 09, 2026, Green Cross (005250) is trading at a price of 9,840 KRW, with a previous close of 9,680 KRW. The stock has fluctuated within a day range of 9,680 KRW to 9,950 KRW, while its 52-week range spans from 9,580 KRW to 18,010 KRW.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.